Lipoprotein (a)(Lp (a)) is a low-density lipoprotein (LDL) cholesterol-like particle bound to
apolipoprotein (a). Increased Lp (a) levels are an independent, heritable causal risk factor …

Malignant coronary artery disease (CAD) refers to a severe and extensive atherosclerotic
process involving multiple coronary arteries in young individuals (aged< 45 years in men …

Objectives: The purpose of this study is investigate the effects of variants in the
apolipoprotein (a) gene (LPA) on vascular diseases with different atherosclerotic and …

Background—Experimental studies have suggested both atherogenic and thrombogenic
properties of lipoprotein (a)[Lp (a)], depending on Lp (a) plasma concentrations and varying …

Lp (a) was identified as a novel antigen by Kare Berg in 1963. 1 Mounting evidence from
prospective epidemiologic and clinical studies over the past four decades show that …

Although many epidemiologic studies have pointed at an association between plasma
levels of lipoprotein (a)(Lp (a)) and cardiovascular risk, the data obtained have been …

Most studies aiming to detect associations of genetic variation with common complex
diseases, eg coronary heart disease (CHD) have been performed in populations with a …

In an attempt to search for risk factors which can explain the increasing prevalence of
coronary heart disease (CHD) in Indian population, we conducted a case-control study to …

BACKGROUND: We have recently reported that homozygosity for the minor A-allele of
RAGE (receptor for advanced glycation end products)− 374T/A polymorphism may exert a …

BACKGROUND: Few and conflicting data are available in the literature on the association
between Lp (a) levels and the severity of coronary artery disease (CAD) in diabetic patients …